null

Human CellExp™ SARS-CoV-2 Spike RBD (E484K)

(No reviews yet) Write a Review
SKU:
26-P1649
Availability:
Usually Shipped in 5 Working Days
Size:
50 μg
Storage Temperature:
-20ºC
Shipping Conditions:
Gel Pack
Shelf Life:
12 months
zł2,175.50
Frequently bought together:

Description

Biomolecule/Target: N/A

Synonyms: COVID-19 Spike RBD protein (E484K); 2019-nCoV Spike RBD protein (E484K); SARS-CoV-2 Mutant (E484K); SARS-CoV-2 (E484K) mutant protein

Alternates names: COVID-19 Spike RBD protein (E484K); 2019-nCoV Spike RBD protein (E484K); SARS-CoV-2 Mutant (E484K); SARS-CoV-2 (E484K) mutant protein

Taglines: Spike RBD variant with E84k mutation which mildly increase receptor binding

Taglines: USA

Country of Animal Origin: USA

NCBI Gene ID #.: N/A

NCBI Gene Symbol: N/A

Gene Source: Coronavirus

Accession #: YP_009724390.1

Recombinant: 1

Source: Hek293

Purity by SDS-PAGE #: ≥ 90% by SDS-PAGE

Assay: N/A

Purity: N/A

Assay #2: N/A

Endotoxin Level: N/A

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: 35 kDa

Concentration: N/A

Appearance: Lyophilized protein

Physical form description: N/A

Reconstitution Instructions: Reconstitute in sterile water to a concentration of 1 mg/ml.

Background Information: SARS-CoV-2 Spike protein is a large type I transmembrane protein composed of S1 subunit and S2 subunit. During viral infection, the receptor-binding domain (RBD) of the S1 subunit is responsible for the recognition and binding of host receptor ACE2, while the S2 subunit mediates viral cell membrane fusion. The SARS-CoV-2-S1-RBD/ACE2 interaction mediates viral entry into the target cells. The E484K mutant mildly increase receptor binding.

Amino acid sequence: The target protein SARS-CoV-2 S Protein RBD (E484K) is expressed with His tag at the C-terminus.

Handling: Centrifuge the vial prior to opening.

Usage: For Research Use Only! Not to be used in humans

View AllClose